TABLE 2.

Univariate analysis results.

Variable	Statistics	HR (95%CI) P-value
TEVAR timing	21.2 ± 24.4	1.0 (1.0, 1.0) 0.097
Age	52.0 ± 10.6	1.1 (1.0, 1.1) 0.002
Gender (female)	10 (3.3%)	2.5 (0.6, 10.9) 0.210
BMI	26.4 ± 4.1	1.0 (0.8, 1.1) 0.481
Hypertension	226 (73.9%)	1.0 (0.4, 2.4) 0.996
CAD	15 (4.9%)	0.7 (0.1, 5.3) 0.745
Diabetes	11 (3.6%)	3.2 (1.0, 10.9) 0.058
Alcohol consumption	121 (39.5%)	1.3 (0.6, 3.0) 0.462
Number of stents used
1	266 (87.5%)	1
2	34 (11.2%)	2.6 (1.0, 6.9) 0.060
3	4 (1.3%)	0.0 (0.0, Inf) 0.998
Stent brand
Talent	9 (2.9%)	1
Valiant	82 (26.8%)	0.7 (0.1, 4.5) 0.734
GRIMED	75 (24.5%)	1.2 (0.2, 5.5) 0.856
Hercules	47 (15.4%)	1.6 (0.3, 7.7) 0.575
Zenith TX2	38 (12.4%)	1.0 (0.1, 12.2) 0.998
Relay	34 (11.1%)	1.6 (0.2, 10.7) 0.627
E-vita	21 (6.9%)	1.4 (0.1, 16.4) 0.812
Hybrid	3 (1.0%)	0.0 (0.0, Inf) 0.998
Chimney TEVAR	15 (4.9%)	0.0 (0.0, Inf) 0.997

Values are presented as the mean ± standard deviation or n (%) or HR (95% CI) P-value. BMI, body mass index; CAD, coronary artery disease; TEVAR, thoracic endovascular aortic repair.